L3: Measuring agonist and antagonist activity part 2 (there is more) Flashcards
agonist (A) binding?
XA + (Ntot-NA) (forward reverse arrows) NA
The n things: gives you number of receptors not bound
NA: Number of receptors bound by agonist
at equillibirum number of drug molecules binding is equal and opposite to those unbinding
XA= agonist concentration
Hill-Langmuir equation
what us an agonist
an agonist binds to a receptor and also elicits a response
A+R reverisble arrows
(affinity)
to AR reverisble arrows
receptor activation
(efficacy)
to AR*
This response can be opening of an ion channel, activation of a G-protein
or activation of an enzyme depending on the receptor type
An agonist is a drug with affinity (KA) and efficacy both of which can be quantified
full agonist: A full agonist has high efficacy i.e. produces a maximal effect before all available receptors are occupied
NEED TO KNOW CONC AND LOG CONC RESPONSE CURVES
ec50
Effective concentration which produces 50% of the maximal effect
A functional measure
A product of both affinity and efficacy
IC50 – Concentration to produce 50% inhibition
LD50 - Dose to produce death in 50% of the subjects
PARTIAL agonists
Has affinity for the receptor but low efficacy
It will not produce a maximum response
has low efficacy i.e. occupies all of the available receptors without producing a maximal response
inverse agonists
A recent concept
In the past most experiments assumed basal activity of a receptor was zero
A+R—-> AR—-> AR*
an agonists increases the probability of receptor activation
but
R—-> R*
in absence of agonist, receptor activation is not 0
There is some evidence for this constitutive activity indeed some diseases
are cause by mutant receptors that a highly constitutively active
Then some drugs might reduce the number of activated receptors at rest
These are termed inverse agonists
An inverse agonist reduces constitutive receptor activation
pharmacology, homeopathy and herbal medicine
Homeopathy: giving patients medicines that contain no medicine whatsoever
Herbal medicine: giving patients an unknown dose of an ill-defined drug, of unknown effectiveness and unknown safety
Pharmacology is based on physiochemical constants that describe the binding of drugs to receptors
competitive reversible antagonists
Has affinity but zero efficacy
It binds to the receptor but induces no response
However it binds in such a way to prevent agonist binding (competes)
PA2 and KB
pA2 is the negative log10 of the concentration of antagonist required to shift the agonist concentration response curve 2-fold to the right
pA2 = 50% of the receptors occupied by antagonist therefore pA2 = KB
This means we do not have to do binding experiments to measure the equivalent of the KB
So if pA2 = 9.0 then 1 x 10-9 M (1 nM)
It is independent of the agonist used
why kb (PA2) is better at defining receptor affinity than KA:
Can compare binding data (KB) with functional data (pA2)
Competitive antagonist have zero efficacy
KA can change when receptor is bound by its effector
Uncoupled receptor has high affinity for agonist
A receptor when coupled to a G-protein has lower affinity for agonist
The same receptor coupled to different G-proteins may have different KAs for the same agonist